The Vision Behind Artemis
The Partnership behind Artemis and UBC – Where time, place, and minds align.
Rooted in a heritage of learning and scientific rigor, and through our partnership with the University of British Columbia, Artemis honours the long arc of discovery — knowing that timing matters as much as insight.
Symbolic of the iconic clock tower anchoring campus mindshare and connection, and subtly shaped by West Coast imagery, Artemis wanted to convey balance, perspective, and quiet confidence to bold ideas, grounded in nature and open horizons.
At our centre is collaboration: different minds leaning into one shared mission, where trust, curiosity, and collective intelligence turn questions into progress.
This is discovery born of place, guided by legacy, and advanced together.
About Artemis Therapeutics
Artemis Therapeutics was founded by Dr. Artem Cherkasov and Dr. Mads Daugaard, bringing together more than three decades of leadership in molecular modelling, machine learning, and drug validation. Positioned at the intersection of computational science and translational medicine, Artemis combines deep technical expertise with real-world therapeutic ambition.
At its core is a proprietary AI-driven discovery platform designed to accelerate the identification of safe and effective drug candidates. By integrating advanced computational methods with rigorous biological validation, Artemis transforms complex molecular data into precise, actionable insight.
The platform is already proven: six drug candidates identified using Artemis technology have been licensed to pharmaceutical partners. This success is grounded in a strong record of scientific excellence, including two international drug discovery competition wins led by Dr. Cherkasov.
Structured as an asset-driven biopharma company, Artemis advances its own therapeutic programs to capture the full value of innovation while maintaining strategic focus and scientific integrity. Its leadership team and Scientific Advisory Board include globally recognized pioneers in AI-enabled drug discovery, oncology, and translational medicine — bridging visionary science with disciplined execution.
Let's Advance Discovery Together
If you are interested in partnering, investing, or exploring scientific collaboration, we welcome the conversation.